Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70

Area of Science:

• Molecular Biology
• Cancer Biology
• Biochemistry

Background:

• Histone deacetylases (HDACs) regulate gene transcription and are overexpressed in various tumors, correlating with poor prognosis.
• Approved HDAC inhibitors treat specific lymphomas and multiple myeloma, impacting gene expression via histone acetylation.
• Apoptosis, or programmed cell death, is a primary mechanism for HDAC inhibitor-induced cancer cell death.

Purpose of the Study:

• To investigate the role of Ku70 acetylation in HDAC inhibitor-mediated apoptosis.
• To identify Ku70 as a potential therapeutic target for HDAC inhibitor treatment.

Main Methods:

• Analysis of gene transcription regulation by HDACs.
• Assessment of apoptosis induction by HDAC inhibitors.
• Investigation of Ku70 protein acetylation and its downstream effects on c-FLIP and Bax.

Main Results:

• HDAC inhibitors induce Ku70 acetylation in cancer cells.
• Ku70 acetylation leads to repression of the anti-apoptotic protein c-FLIP.
• Ku70 acetylation results in the activation of the proapoptotic protein Bax.

Conclusions:

• Ku70 is a key target of HDAC inhibitors, mediating apoptosis in cancer cells.
• HDAC inhibitors' mechanism involves Ku70 acetylation, influencing the balance of apoptotic proteins.
• Targeting Ku70 acetylation presents a promising strategy for cancer therapy.